CB Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 18
Employees
  • Latest Deal Type
  • Series A
  • Investors
  • 14

CB Therapeutics General Information

Description

Operator of a biotechnology company intended to offer tryptamines, cannabinoids, and their analogs to treat various diseases. The company's cellular agriculture platform enables next-generation biosynthetic production of cannabinoids and psychedelic medicines and their analogs to further clinical research for various serious health conditions, thereby enabling the healthcare industry to address mental health issues and increase healthspan.

Contact Information

Website
www.cbthera.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Primary Office
  • 2717 Loker Avenue West
  • Suite A
  • Carlsbad, CA 92010
  • United States

CB Therapeutics Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CB Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series A) 10-May-2021 00.000 Completed Startup
9. Early Stage VC 16-Apr-2019 00.00 00.000 Completed Startup
8. Accelerator/Incubator 22-Aug-2018 00000 00000 00.000 Completed Startup
7. Early Stage VC 15-Aug-2018 Completed Startup
6. Accelerator/Incubator 25-Jul-2017 Completed Startup
5. Grant 03-Dec-2015 00.00 Completed Startup
4. Grant 23-Nov-2015 000 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator 14-Apr-2015 Completed Startup
1. Accelerator/Incubator Completed Startup
To view CB Therapeutics’s complete valuation and funding history, request access »

CB Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Sher Butt Co-Founder, Chief Executive Officer & Board Member
Jacob Vogan Ph.D Co-Founder, CSO & Board Member
Thanos Karavokiris Vice President of Operations
Zhēn Qī Co-Founder
Christian Angermayer Advisor
You’re viewing 5 of 6 executive team members. Get the full list »

CB Therapeutics Board Members (5)

Name Representing Role Since
Jacob Vogan Ph.D CB Therapeutics Co-Founder, CSO & Board Member 000 0000
Jan Hardorp re.Mind Capital Board Member 000 0000
Jeffrey Miller Ph.D Self Board Member 000 0000
Sher Butt CB Therapeutics Co-Founder, Chief Executive Officer & Board Member 000 0000
Srinivas Rao Ph.D Self Board Member 000 0000
To view CB Therapeutics’s complete board members history, request access »

CB Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CB Therapeutics Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
re.Mind Capital Venture Capital Minority 000 0000 000000 0
C3 Ventures (VC) Venture Capital Minority 000 0000 000000 0
Fort Ventures Venture Capital Minority 000 0000 000000 0
LYVC Venture Capital Minority 000 0000 000000 0
Y Combinator Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »